Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03470181 · ClinicalTrials.gov registry record
Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 24
- Enrollment target
NCT03470181: Completed study, sponsored by The Cleveland Clinic.
NCT03470181 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03470181 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Cyclic vomiting syndrome is a disorder characterized by nausea and vomiting, separated by periods without any symptoms. There is very little research on this field at this point and most doctors do not fully understand the disorder. The goal of this study is to assess how the stomach empties food. Participants will be asked to participate in this study because either (a) they have been diagnosed and/or treated for cyclic vomiting syndrome in the past, or (b) they are physically healthy. The study seeks to compare how a healthy person's stomach empties to how the stomach of someone with cyclic vomiting disorder empties.
Primary Outcome
The amount of nutrient drink consumed before the participant reports feelings of unbearable fullness.
Interventions
- DIETARY_SUPPLEMENT Ensure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2018-05-29 |
What the finished NCT03470181 record still lists
NCT03470181 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ensure is the first listed.
NCT03470181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03470181 about?
NCT03470181 is a clinical study titled "Applying Nutrient Drink Test in Understanding Pathophysiology of CVS". Cyclic vomiting syndrome is a disorder characterized by nausea and vomiting, separated by periods without any symptoms. There is very little research on this field at this point and most doctors do not fully understand the disorder. The goal of this study is to assess how the stomach empties food. P...
What is the current status of trial NCT03470181?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2018-02-01. Estimated completion is 2018-05-29.
What interventions are being tested in trial NCT03470181?
The interventions under investigation include: Ensure (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03470181?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI